Kudos will help Pfizer increase the reach and engagement of its clinical research by showcasing summaries and related content on a centralized platform.

OXFORD, UK — July 23rd, 2025 — Kudos, the platform for showcasing research, has announced that it has been chosen by Pfizer to support the dissemination of the latter’s scientific publications. Kudos will host clinical summaries and links to related content such as peer-reviewed articles, infographics, conference posters, videos, fact sheets, and more. The first treatment areas to benefit will be Inflammation and Immunology, Internal Medicine, and Vaccines. 

Pfizer content will be summarized and showcased alongside prestigious content from Kudos’ partnerships with academic publishers and universities. By centralizing discovery, and guiding audiences on a more curated journey through different content, Kudos will help Pfizer maximize visibility. The Kudos platform includes  a rich suite of metrics including citation counts for publications, views of related content, and audience insights. 

Rushi Dave, Publications Specialist at Pfizer, explains the company’s goals in working with Kudos: “By partnering with Kudos, we’re helping to ensure our clinical data and publications reach more of the right people, at the right time.”

“This partnership reflects a shared ambition to improve the transparency and reach of medical publications,” says Charlie Rapple, co-founder of Kudos. “We are delighted to be supporting Pfizer in accelerating the positive effects of clinical research.”

For more information, visit info.growkudos.com/pharma or contact Sarah.Mustapha@growkudos.com.

– ENDS –

About Kudos

Kudos (growkudos.com) is the platform for showcasing research, helping more people find, understand and use it. Over 575,000 researchers and practitioners use Kudos to bring science to life through the power of storytelling. Kudos is the only toolkit designed specifically to drive research communications, engagement and impact, helping researchers cross boundaries, achieve more influence, and gain more recognition.

About Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News,LinkedIn,YouTube and like us on Facebook at Facebook.com/Pfizer.